Compare IDEXX Laboratories, Inc. (IDXX) vs Intel Corp (INTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Intel Corp — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Intel Corp trades at $104.7 (market cap $566.04B). The key difference: Intel Corp is far larger — about 14× IDEXX Laboratories, Inc.'s market cap, and Intel Corp pays a 2.24% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Intel Corp for 116 Days on average.
| IDXX | INTC | |
|---|---|---|
Market Cap | $40.43B | $566.04B |
Volume | 692,164 | 118,475,837 |
Sector | Health | Technology |
52-Week High | $766.68 | $140.94 |
52-Week Low | $504.70 | $33.62 |
Typical Hold Time | 46 Days | 116 Days |
Enterprise Value | $41.32B | $586.85B |
Dividend Yield | — | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Intel (INTC) trades at $107.08, down 5.34% over 24 hours, with a bullish technical breakout pattern despite near-term bearish momentum indicators. The company reported three consecutive quarterly EPS beats but posted a net loss of -$267 million in 2025, with revenue declining to $52.85 billion. Intel Foundry's 31% year-over-year growth in Q2 2026 and High-NA chipmaking progress highlight its strategic pivot, though profitability remains challenged with a negative net margin of -0.51%.
Intel's outlook balances a 222% stock surge in 2026 against high valuation multiples and persistent margin pressures. Investment opportunities lie in its foundry turnaround and AI infrastructure positioning, but risks include intense competition, execution challenges, and debt levels. Analyst consensus is cautious with a $111.72 price target and 54% hold ratings, signaling wait-and-see sentiment amid volatile fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
